AI and predictive modeling to understand an individual’s immune system function and predict treatment response are still in very early stages. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only about 20 percent of human coding genes are well-studied. The remaining 80 percent (about 16,000 genes, along with the proteins they make) are largely a mystery.
In this episode, you will hear more about the field of immuno-oncology, understand the correlation between tumor development and immune system response, and trends in cancer detection and prevention, especially liquid biopsies - tests for detecting tumors in blood samples.
Speaker: Brian Hashemi - Executive Chairman and CEO of Novigenix - a Swiss-based biotech company using AI and RNA sequence analysis to capture the cancer immunity cycle during the multi-stage disease progression and response to therapy.
www.facesofdigitalhealth.com
https://fodh.substack.com/
Show notes:
[00:02:00] The use of AI and RNA sequence analysis in capturing the cancer immunity cycle and disease progression
[00:04:00] Biotech in Switzerland
[00:06:00] The impact of Swiss biotech capabilities on global healthcare and the specific advancements made by Swiss companies in the field.
[00:08:00] Predictions and hopes for the future of healthcare technology, especially in the realms of cancer detection and treatment.
[00:10:00] Challenges and opportunities in biotech, and the role of AI in advancing healthcare.
[00:12:00] Challenges in Colorectal Cancer Screening
[00:14:00] The Impact of Liquid Biopsy on Clinical Trials and Drug Development
[00:16:00] Market Adoption and Patient Accessibility to Liquid Biopsy Tests
[00:18:00] The Future of Liquid Biopsy and Precision Medicine
[00:20:00] Real-world Application and Impact of Novel Biomarkers
[00:22:00] Expanding the Reach of Novel Diagnostics Beyond Switzerland
[00:24:00] Partnerships and Collaborations to Accelerate Adoption
Cancer Series Ep. 2: Cancer, Genomics and Data Science
Cancer Series Ep. 1: Access to Care, Financial Toxicity and Healthcare IT in Oncology
The Power Of At-Home Diagnostics and Prevention of STDs (Ash Wellness)
Kenya, Rwanda, Ghana: How is Medtronic Labs Redefining Chronic Disease Management
South Africa & Africa More Broady: What’s The State of Medical Device Regulation?
What Makes Hospital Medication Management Complex? (Talking Healthtech Summit)
EIT Health Germany Series 7: How Can A Digital Health Solution Become a "DiGA App" in Germany?
How is AI in Prosthetics Augmenting Humans? (Dima Gazda, Esper Bionics)
Best of 2021: Taiwan and its Healthcare Digitalization (Yu-Chuan Jack Li)
EIT Health Germany Series 6: Crowdfunding Doesn't Work for Healthcare and the Rise of Digital Visual Stress
Best of 2021: (OVER)DOSE - How Can We Prevent Medication Errors and Patient Harm?
Sleep and Digital Health in Brazil (Renata Redondo Bonaldi)
What Do Patients Really Think About Data? (EPF Congress 2022)
Healthcare in APAC 4/4: Pakistan: Making The Best of Existing Technology With a Strategic Approach (Zahid Ali)
Healthcare in APAC 3/4: Digital Health in APAC: An Overview (Keren Priyadarshini, Microsoft Asia)
(TRAILER) The State of the Right To Be Forgotten for Cancer Survivors in Europe (dr. Françoise Meunier)
Healthcare in APAC 2/4: Why is Australia Not a Global Exemplar in Telehealth? (Peter Birch)
Healthcare in APAC 1/4: Doctors and Healthcare in Malaysia (Selina Chew)
What Do Doctors Want? (Abeyna Bubbers Jones)
SPELLED OUT: How is Pharma Taking Advantage of Digital Health?
Create your
podcast in
minutes
It is Free
Insight Story: Tech Trends Unpacked
Zero-Shot
Fast Forward by Tomorrow Unlocked: Tech past, tech future
The Unbelivable Truth - Series 1 - 26 including specials and pilot
Lex Fridman Podcast